TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.

Robert J Kreitman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.